Moneycontrol PRO
Upcoming Webinar:Join us for Sustainability 100+ Dialogues 2021-Maharashtra Roundtable& know how the state is progressing on climate action
you are here: HomeNewsBusiness

Buy Solara Active Pharma Sciences; target of Rs 1700: Sharekhan

Sharekhan is bullish on Solara Active Pharma Sciences has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated February 03, 2021.

February 09, 2021 / 10:47 PM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Solara Active Pharma Sciences

Solara delivered its best-ever quarterly performance for Q3FY2021 with revenues and earnings staging an impressive 24% and 59% y-o-y, growth respectively. Given the strong demand traction and ramp up of the Vizag plant (Phase I), strong new product launches, especially in the limited competition space augur well from a growth perspective. The company’s strong growth prospects, better earnings visibility, healthy balance sheet, and improving return ratios would support multiple expansion.


We retain our Buy recommendation on Solara Active Pharma Sciences (Solara) with a revised PT of Rs. 1700.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Feb 9, 2021 10:47 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark